Substance / Medication

Magaldrate

Overview

Active Ingredient
magaldrate
RxNorm CUI
29151

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Vonoprazan vs. Lansoprazole for the treatment of endoscopic submucosal dissection induced gastric ulcer: a systematic review and meta-analysis.
Miao Tiaotiao, Zhang Yao, Bai Lin et al. · Rev Esp Enferm Dig · 2023
PMID: 35899702Meta-Analysis
Meta-analysis of the association between new hypoglycemic agents and digestive diseases.
Wang Yu-Wen, Lin Jin-Hao, Yang Cui-Shan · Medicine (Baltimore) · 2022
PMID: 36042668Meta-AnalysisFull text (PMC)
Evidence-Based Guidelines for the Treatment ofInfection in Korea 2020.
Jung Hye-Kyung, Kang Seung Joo, Lee Yong Chan et al. · Gut Liver · 2021
PMID: 33468712Meta-AnalysisFull text (PMC)
Duodenal ulcer perforation: A systematic literature review and narrative description of surgical techniques used to treat large duodenal defects.
Clinch Darja, Damaskos Dimitrios, Di Marzo Fransesco et al. · J Trauma Acute Care Surg · 2021
PMID: 34254960Meta-Analysis
Laparoscopic Repair for Perforated Peptic Ulcer Disease Has Better Outcomes Than Open Repair.
Quah Gaik S, Eslick Guy D, Cox Michael R · J Gastrointest Surg · 2019
PMID: 30465190Meta-Analysis
Evaluation of Aluminum and Magnesium Absorption Following the Oral Administration of an Antacid Suspension Containing Magaldrate in Healthy Women Under Fed Conditions.
Burgos Castillo Maria Juliana, Cruz Palacios Maria Juliana, Iorgatchof Xavier Kamila et al. · Adv Ther · 2024
PMID: 39249590RCTFull text (PMC)
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.
Giannini Edoardo G, Zentilin Patrizia, Dulbecco Pietro et al. · Dig Dis Sci · 2006
PMID: 16977507Observational
Stability studies of aspirin-magaldrate double layer tablets.
al-Gohary O M, al-Kassas R S · Pharm Acta Helv · 2000
PMID: 10812933Other
Antiulcer activity and the mechanism of action of magaldrate in gastric ulceration models of rat.
Patel A V, Santani D D, Goyal R K · Indian J Physiol Pharmacol · 2000
PMID: 10941626Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Magaldrate (substance)
SNOMED CT
387240004
UMLS CUI
C0065512
RxNorm CUI
29151

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.